Filtros de búsqueda

Lista de obras de Armando Orlandi

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.

artículo científico publicado en 2017

A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study

artículo científico publicado en 2019

AMAROS Study: Overall Survival in Breast Cancer Subtypes.

artículo científico publicado en 2015

Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line.

artículo científico publicado en 2011

Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy

scientific article published on 09 July 2020

Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis.

artículo científico publicado en 2015

BRAF in metastatic colorectal cancer: the future starts now.

artículo científico publicado en 2015

Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians.

artículo científico

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.

artículo científico publicado en 2016

Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study

artículo científico publicado en 2017

ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas.

artículo científico publicado en 2015

Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis

artículo científico publicado en 2018

Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse

artículo científico publicado en 2016

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

artículo científico publicado en 2017

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.

artículo científico publicado en 2017

Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?

artículo científico publicado en 2011

KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study

artículo científico publicado en 2015

KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients.

artículo científico publicado en 2012

LUX-Lung 7: is there enough data for a final conclusion?

Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report.

artículo científico publicado en 2011

Menopausal hormone therapy: What should be kept in mind for a personalized choice in a shared decision-making

scientific article published on 09 December 2019

Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.

artículo científico publicado en 2017

New challenges in multimodal workout of locally advanced breast cancer.

artículo científico publicado en 2017

New life for retrospective study in the precision oncology era.

artículo científico publicado en 2015

Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series

scientific article published on 18 December 2020

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

artículo científico publicado en 2018

Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series.

artículo científico publicado en 2016

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

artículo científico publicado en 2018

Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?

artículo científico publicado en 2019

Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase

artículo científico publicado en 2018

Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

artículo científico publicado en 2015

Targeted therapy in advanced gastric carcinoma: the future is beginning

artículo científico publicado en 2014

The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the 'unexplainable'

artículo científico publicado en 2018

Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report.

artículo científico publicado en 2015

Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren's Classification in Pan-Cancer Analysis Era?

scientific article published on 01 July 2020

Usefulness of automated breast volume scanner (ABVS) for monitoring tumor response to neoadjuvant treatment in breast cancer patients: preliminary results

scientific article published on 01 January 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda